The Enterprise Value as of November 2025 (TTM) for Arena Pharmaceuticals, Inc. (ARNA) is -183361000.00

According to Arena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -183361000.00. This represents a change of -104.51% compared to the average of 4.06B of the last 4 quarters.

Arena Pharmaceuticals, Inc. (ARNA) Historical Enterprise Value (quarterly & annually)

How has ARNA Enterprise Value performed in the past?

The mean historical Enterprise Value of Arena Pharmaceuticals, Inc. over the last ten years is 1.80B. The current -183361000.00 Enterprise Value has changed -1117.58% with respect to the historical average. Over the past ten years (40 quarters), ARNA's Enterprise Value was at its highest in in the December 2021 quarter at 5.52B. The Enterprise Value was at its lowest in in the December 2016 quarter at 320.08M.

Arena Pharmaceuticals, Inc. (ARNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arena Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arena Pharmaceuticals, Inc. (ARNA) Average Enterprise Value

How has ARNA Enterprise Value performed in the past?

The current Enterprise Value of Arena Pharmaceuticals, Inc. (ARNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arena Pharmaceuticals, Inc. (ARNA) Enterprise Value vs. Peers

How is ARNA’s Enterprise Value compared to its peers?

Arena Pharmaceuticals, Inc.’s Enterprise Value is less than IVERIC bio, Inc. (5.13B), less than Reata Pharmaceuticals, Inc. (6.64B), less than Abcam plc (134.60M), less than Roivant Sciences Ltd. (13.59B), less than Mirati Therapeutics, Inc. (3.93B), less than Cerevel Therapeutics Holdings, Inc. (7.68B), less than Opthea Limited (463.02M), less than SpringWorks Therapeutics, Inc. (3.48B), less than R1 RCM Inc. (8.19B), less than MorphoSys AG (2.93B),

Build a custom stock screener for Arena Pharmaceuticals, Inc. (ARNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arena Pharmaceuticals, Inc. (ARNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.